Anesiva initiates phase III clinical trial of Adlea in postsurgical pain following knee surgery April 10, 2008
Biovitrum reports promising results from phase II study of BVT-115959 in neuropathic pain April 10, 2008
Targeted Genetics acquires full exclusive rights to HD program from Sirna Therapeutics April 10, 2008
Urigen closes phase II clinical trial of URG-101 based on positive interim analysis results April 9, 2008
RSS